[ Price : $8.95]
FDA accepts for review a Pacira Pharmaceuticals NDA for Exparel (bupivacaine), a long-acting drug for postsurgical pain management...[ Price : $8.95]
Vivus says it has responded to points raised in an FDA complete response letter on its obesity drug Onexa.[ Price : $8.95]
Deloitte Research says some life-science hesitation over using social networks may involve a misperception of how best they can be...[ Price : $8.95]
FDA grants a 12-month extension to Hemispherx Biopharma for the company to modify its NDA in response to a 11/25/09 complete respo...[ Price : $8.95]
FDA approves a Tibotec Therapeutics supplemental NDA that revises the dosing recommendation to include once-daily Prezista (daruna...[ Price : $8.95]
FDA warns that accidentally ingesting branded and generic forms of benzonatate by children under age 10 can lead to overdose and d...[ Price : $8.95]
Eli Lilly suspends for safety reasons a global Phase 3 study evaluating tasisulam, an investigational, anti-cancer compound for us...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Abbotts Freestyle Navigator for the purpose of patent ext...